The original rise of Viagra presented a considerable chance for the market, but its exclusivity has expired , creating a intricate landscape. Alternative versions have entered the space , eroding profits and putting pressure on profit yields. While major healthcare companies continue a foothold in this sector , the outlook looks unclear by intense